Stockscreener 앱 받기
1.84
4.66%
-0.09
시간 외 거래:
1.86
0.02
+1.09%
전일 마감가:
$1.93
열려 있는:
$2
하루 거래량:
2.40M
Relative Volume:
4.00
시가총액:
$115.87M
수익:
$233.00K
순이익/손실:
$-64.61M
주가수익비율:
-1.595
EPS:
-1.1536
순현금흐름:
$-58.32M
1주 성능:
-17.49%
1개월 성능:
-11.11%
6개월 성능:
-28.96%
1년 성능:
+3.37%
1일 변동 폭
$1.74
$2.03
1주일 범위
$1.74
$2.93
52주 변동 폭
$1.23
$3.82
코넥트 바이오파마 Stock (CNTB) Company Profile
명칭
Connect Biopharma Holdings Ltd
전화
858-727-1040
주소
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
1.84 | 143.58M | 233.00K | -64.61M | -58.32M | -1.1536 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
코넥트 바이오파마 Stock (CNTB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 개시 | Lake Street | Buy |
| 2025-10-31 | 개시 | BTIG Research | Buy |
| 2025-06-12 | 개시 | H.C. Wainwright | Buy |
| 2024-03-04 | 개시 | H.C. Wainwright | Buy |
| 2021-04-13 | 개시 | Jefferies | Buy |
| 2021-04-13 | 개시 | Piper Sandler | Overweight |
| 2021-04-13 | 개시 | SVB Leerink | Outperform |
모두보기
코넥트 바이오파마 주식(CNTB)의 최신 뉴스
A Sept. 15 live webcast will feature Connect Biopharma management - Stock Titan
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate - simplywall.st
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma stock rating reiterated at Buy by Canaccord - Investing.com South Africa
Will Connect Biopharma (CNTB) Breathe Easy After Seabreeze Trials? - RTTNews
Connect Biopharma Holdings Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
HC Wainwright Issues Pessimistic Forecast for CNTB Earnings - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Ikarian Capital (CNTB) discloses 6.9% Connect Biopharma holding on Schedule 13G/A - Stock Titan
Connect Biopharma (CNTB) investor Wei Zheng discloses 4% beneficial stake - Stock Titan
Connect Biopharma Holdings Ltd expected to post a loss of 21 cents a shareEarnings Preview - TradingView
H.C. Wainwright Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Connect Biopharma Holdings earnings beat by ¥0.33, revenue topped estimates - Investing.com Canada
Connect Biopharma Holdings earnings beat by ¥0.34, revenue topped estimates - Investing.com
Connect Biopharma Q2 Results: Net Loss Widens To $17.3 Million - scanx.trade
Connect Biopharma (NASDAQ:CNTB) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Connect Biopharma (CNTB) ramps rademikibart spend as losses deepen in 2026 - Stock Titan
Connect Biopharma Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Connect Biopharma (CNTB) widens Q2 2026 loss as R&D rises, cash at $31.5M - Stock Titan
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
Connect Biopharma Holdings Ltd (CNTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma Holdings Ltd (CNTB) Stock News Today - TradingKey
Connect Biopharma (CNTB) Projected to Release Earnings on Wednesday - MarketBeat
CNTB|Connect Biopharma Holdings Ltd|Price:2.020|Chg%:-0.070 - TradingKey
ADAR1 Capital Management LLC Invests $1.95 Million in Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat
Connect Biopharma Holdings Ltd (CNTB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CNTB|Connect Biopharma Holdings Ltd|Price:2.110|Chg%:-0.030 - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Balance Sheet - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Income Statement - TradingKey
CNTB|Connect Biopharma Holdings Ltd|Price:2.140|Chg%:-0.060 - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BIO 2026: Catching Up With Vaxart, Aphaia, Connect Biopharma, Kyverna And Chugai - insights.citeline.com
Lake Street Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Oppenheimer Initiates Connect Biopharma(CNTB.US) With Buy Rating, Announces Target Price $8 - Moomoo
CNTB Initiates Coverage by Oppenheimer -- Rating Set to Outperfo - GuruFocus
Oppenheimer initiates Connect Biopharma stock with outperform rating By Investing.com - Investing.com Nigeria
Oppenheimer initiates Connect Biopharma stock with outperform rating - Investing.com
CNTB Stock Price, Quote & Chart - ChartMill
CNTBConnect Biopharma Holdings Ltd Dividends - Finviz
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - MPNnow.com
Form 4 Connect Biopharma Holdings Ltd For: 1 July By Investing.com - Investing.com Canada
Connect Biopharma (CNTB) director granted 3,738 fully vested shares as fees - Stock Titan
Connect Biopharma (NASDAQ: CNTB) director receives 6,718-share award as 2026 board compensation - Stock Titan
CCORF Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Connect Biopharma Holdings Limited(NasdaqGM: CNTB) added to Russell 2000 Index - marketscreener.com
Connect Biopharma Holdings Limited(NasdaqGM: CNTB) added to Russell Microcap Index - marketscreener.com
Piper Sandler initiates Connect Biopharma stock with overweight rating By Investing.com - Investing.com Nigeria
코넥트 바이오파마 (CNTB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
코넥트 바이오파마 주식 (CNTB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Huang James | Director |
Mar 31 '26 |
Buy |
3.45 |
1,160,000 |
4,002,000 |
13,160,000 |
0.86%
0.31%
자본화:
|
볼륨(24시간):